Authors:
KOVACS MJ
WEIR K
MACKINNON K
KEENEY M
BRIEN WF
CRUICKSHANK MK
Citation: Mj. Kovacs et al., BODY-WEIGHT DOES NOT PREDICT FOR ANTI-XA LEVELS AFTER FIXED-DOSE PROPHYLAXIS WITH ENOXAPARIN AFTER ORTHOPEDIC-SURGERY, Thrombosis research, 91(3), 1998, pp. 137-142
Authors:
TURPIE AGG
GENT M
CRUICKSHANK MK
KOVACS MJ
RUDDY TD
BASILE F
LATOUR Y
LAUPACIS A
HIRSH J
Citation: Agg. Turpie et al., RANDOMIZED COMPARISON OF MODERATE (INR-3.0-3.5) WITH LOW-INTENSITY (INR-2.0-3.5) ANTICOAGULANT-THERAPY IN PATIENTS WITH PROSTHETIC HEART-VALVES TREATED WITH ASPIRIN (100 MG DAY)/, Circulation, 98(17), 1998, pp. 4026-4026
Authors:
TURPIE AGG
CRUICKSHANK MK
LATOUR Y
LAUPACIS A
GENT M
HIRSH J
Citation: Agg. Turpie et al., DOUBLE-BLIND COMPARISON OF ASPIRIN WITH WARFARIN FOLLOWING BIOPROSTHETIC HEART-VALVE REPLACEMENT, Circulation, 94(8), 1996, pp. 3802-3802
Citation: Mk. Cruickshank et J. Black, LACK OF HEPARIN INHIBITOR CARRY-OVER EFFECT ON APTT TESTING ON THE COMPACT THROMBOLYZER, Blood, 86(10), 1995, pp. 3458-3458
Citation: Mk. Cruickshank et al., DEVELOPMENT OF A FACTOR-V AND THROMBIN INHIBITOR FOLLOWING PARTIAL HEPATIC RESECTION AND THE USE OF TOPICAL THROMBIN CONCENTRATE, Clinical and laboratory haematology, 16(2), 1994, pp. 187-190
Citation: Mk. Cruickshank et al., INSENSITIVITY OF ACTIN FS IN THE DETECTION OF NONSPECIFIC INHIBITORS, Archives of pathology and laboratory medicine, 118(1), 1994, pp. 9-9